Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-02

Clinical Trial Update: Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia. [NA]

View source ↗

Summary

A clinical trial evaluating the Diffusing Alpha-emitters Radiation Therapy (DaRT) device for treating skin cancer, oral mucosal cancer, and superficial soft tis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diffusing Alpha-emitters Radiation Therapy (DaRT) device

Snippet

Sponsor: Alpha Tau Medical LTD. | Conditions: Skin Cancer, Mucosal Neoplasm of Oral Cavity | NA | Status: RECRUITING